Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
11/2004
11/10/2004CN1544640A Expression method for high temperature resistant xylanase and specific expression carrier for same
11/10/2004CN1544635A Highly efficient expression of bacillus foecalis alkaligenes penicillin G acylated enzyme in colibacillus
11/10/2004CN1544627A Phase separation method for biomacromolecule components
11/10/2004CN1544624A Double promoter DNA vaccine expression vector pCMVnir and preparation method thereof
11/10/2004CN1544622A Method for preparing phytase by the fermentation of methanol nutrient type recombinant yeast
11/10/2004CN1544621A Method for increasing yield of heat and alkaline resistant catalase prepared by microbiological method
11/10/2004CN1544619A Method for preparing puerarin using hairly pueraria phaseoloides
11/10/2004CN1544618A Biotransformation method for resting cell in cloud point system
11/10/2004CN1544617A Microecological preparation, making method and specific strain thereof
11/10/2004CN1544616A Vibrio and process for producing mannuronic acid lyase by using the same
11/10/2004CN1544615A Vibrio and process for producing guluronicacid lyase by using the same
11/10/2004CN1544614A Bacteria for biocontrol of disease and its application
11/10/2004CN1544613A Lichen bacillus for the production of phytocytomine and plant growth regulator
11/10/2004CN1544612A Pollution controlling method in cultivating nostoc and nostoc commune
11/10/2004CN1544611A Production process of nostoc sphaeroides
11/10/2004CN1544610A Microorganism compositions for degrading straw, preparation thereof and method for degradation of straw
11/10/2004CN1544356A Probiotic bacterium compound formulation preparation method
11/10/2004CN1544355A Aquacultural water body cleaning method using microorganism
11/10/2004CN1543801A Preparation for biological prevention and cure of hot pepper epidemic disease and method for producing the same
11/10/2004CN1175113C Method for increasing yield of recombinant proteins in microbial fermentation processes
11/10/2004CN1175112C Method for produicng exo polysaccharides
11/10/2004CN1175104C Endo-beta-N-acetyl glucosaminidase gene
11/10/2004CN1175101C Process for culturing mycelial fungus in solid nutrient matrix suspension liquid
11/10/2004CN1174681C Changchuan mycin agricultural bactericide and its preparing method and use
11/10/2004CN1174671C Asafetida mushroom culturing process
11/09/2004US6815540 Improved solubility/yield/ease of handling; fusion proteins; for diagnostics/drugs/research
11/09/2004US6815534 Tissue plasminogen activator-like protease
11/09/2004US6815420 Methods of using chemokine beta-6
11/09/2004US6815193 Protease for use in treating textiles, cleaning agents and animal feeds
11/09/2004US6815192 Enzymatic polypeptide for use in detergents and textile processing
11/09/2004US6815191 Endo-β-N-acetylglucosaminidase gene
11/09/2004US6815190 Having improved thermostability; used in the enzymatic hydrolysis of cyclic oligomers of poly(ethylene terephthalate) in the finishing of yarn or fabric from fibers
11/09/2004US6815189 For the synthesis of deacetylated derivatives; gene expression inhibition
11/09/2004US6815182 For diagnosis/therapy/prophyaxis of infections/diseases; vaccines; genetic engineering
11/09/2004US6815181 Nucleic acid molecules encoding human secreted hemopexin-related proteins
11/09/2004US6815180 Human cervical cancer 1 protooncogene and protein encoded therein
11/09/2004US6815171 Two-domain mhc polypeptides include mhc( major histocompatibility complex) class ii-based molecules that covalently linked beta 1 and alpha 1 domains, and mhc class i-based molecules that covalently linked alpha-1 and alpha-2
11/09/2004US6814971 Comprising lecithin, oils, amphiphilic surfactant and an antigen; for protecting pig against a bordetella infections and/or a toxigenic pasteuralla infections
11/09/2004US6814969 Epitopes recognized by t-cells (cd-8/cd-4 antigens) derived from herpetic lesions; fusion proteins; antigen presenting cells; vaccines
11/09/2004US6814967 Polypeptides
11/09/2004US6814961 Method for enhancing stem cell trafficking
11/09/2004CA2304437C Process for the production of naturally folded and secreted proteins
11/09/2004CA2294475C Recombinant materials and methods for the production of limonene hydroxylases
11/09/2004CA2273080C Mutants of the lag-3 proteins, products for the expression of these mutants and use
11/09/2004CA2138137C Diphtheria toxin vaccines
11/09/2004CA1341464C Hepatitis e, an enterically transmitted hepatitis viral agent
11/04/2004WO2004094654A2 Transfection kinetics and structural promoters
11/04/2004WO2004094644A2 Vibrio cholerae proteins expressed during infection
11/04/2004WO2004094633A1 Process for producing recombinant protein in bacterium belonging to the genus rhodococcus
11/04/2004WO2004094631A1 Di-glycosil glyceryl compounds for the stabilisation and preservation of biomaterials
11/04/2004WO2004094624A1 Isolation and use of decay fungi
11/04/2004WO2004094621A2 Polynucleotide encoding a novel trp channel family member, ltrpc3, and splice variants thereof
11/04/2004WO2004094620A2 Truncated baff receptors
11/04/2004WO2004094615A2 Prokaryotic collagen-like proteins and uses thereof
11/04/2004WO2004094476A2 Compositions and methods relating to stop-1
11/04/2004WO2004094445A1 A more stable analog of iso-propylthiogalactoside for induction of protein expression
11/04/2004WO2004094316A2 Bioremediation of petroleum pollution using water-insoluble uric acid as the nitrogen source
11/04/2004WO2004093909A1 Methods to regulate biofilm formation
11/04/2004WO2004093825A2 Methods for obtaining colonization factors from bacterial strains
11/04/2004WO2004093790A2 Yeast ectopically expressing abnormally processed proteins and uses therefor
11/04/2004WO2004093787A2 Use of glycodendrimer reagents for inhibiting adhesion by microorganisms
11/04/2004WO2004033624A3 Bio-based method for making mannitol
11/04/2004WO2004002223A3 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species
11/04/2004WO2003102200A3 Fermentation process using specific oxygen uptake rates as a process control
11/04/2004WO2003102135A3 Control sequences of the human corin gene
11/04/2004WO2003062270A8 Fluorescent protein from aequorea coerulscens and uses therof
11/04/2004WO2003029420A3 Apo-2 ligand variants and uses thereof
11/04/2004US20040221334 Immunoglobulin for use in detection of modified insecticidal protein; immunodiagnostics and heterologous gene expression; tissue engineering and biological pest control
11/04/2004US20040220535 Transferring materials into cells porous silicon
11/04/2004US20040220396 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
11/04/2004US20040220385 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/04/2004US20040220384 Novel ligand and dna thereof
11/04/2004US20040220140 poly n-acetylglucosamine and stored platelets; wound healing agents
11/04/2004US20040220107 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
11/04/2004US20040220092 G-protein coupled receptors
11/04/2004US20040220088 Multiple domain glycoprotein hormones and methods of using
11/04/2004US20040219677 Synthetic genes and bacterial plasmids devoid of cpg
11/04/2004US20040219656 Novel antibacterial and herbicidal compounds and system for screening the same
11/04/2004US20040219652 Enzyme mixture comprising cellulase, xylanase and laccase for degrading waste deposit from animal skins and cleaning farm buildings; leather working
11/04/2004US20040219651 Novel biological floculants and production methods
11/04/2004US20040219648 growing microflora in fermentation medium containing sodium sulfate; extraction; aquaculture; for use in flaxseed, rapeseed, soybean and avocado meal
11/04/2004US20040219644 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents
11/04/2004US20040219643 Dual-specific ligand
11/04/2004US20040219640 Polypeptides homologous to VEGFand BMPI
11/04/2004US20040219639 Immunogenic fusion polypeptide comprising lytic epitopes for use in developing vaccine for prevention of mastitis in dairy cattle; veterinary medicine; immunotherapy
11/04/2004US20040219638 Nucleic acids encoding beta 1,3-galactosyltransferases from C.jejuni
11/04/2004US20040219637 Soluble recombinant botulinum toxins having a C-terminal portion of a heavy chain, a N-terminal portion of a heavy chain and a light chain
11/04/2004US20040219636 Aminopeptidase and the genes thereof
11/04/2004US20040219635 Degradation resistant antihypoxic agents for use in treatment and prevention of hypoxia and ischemic related tissue damage
11/04/2004US20040219634 Hybrid telomerase for generating gene transfer vector; gene therapy
11/04/2004US20040219633 Method of producing recombinant antibodies
11/04/2004US20040219632 T1r3 a novel taste receptor
11/04/2004US20040219629 Increasing carotenoid production in bacteria via chromosomal integration
11/04/2004US20040219605 Fluid planar lipid layer-based membrane-anchored ligand system with defined ligand valency and methods of use thereof
11/04/2004US20040219562 Novel form of the PHGPx protein as a diagnostic marker for male infertility
11/04/2004US20040219553 Alpha-1,2-fucosyltransferase and dna encoding the same
11/04/2004US20040219529 synthetic bovine Deoxyribonulease I as well as variants that are enzymatically active in hydrolyzing DNA with a catalytic profile that is distinct from that of wild type DNase I cleaving nonspecifically to release 5'-phosphorylated nucleotides
11/04/2004US20040219527 Isolated luciferases and the use thereof
11/04/2004US20040219516 Expression vector comprising multiple recombination and/or topoisomerase sites for use as gene transfer tool in ptokaryotic and eukaryotic cells
11/04/2004US20040219237 Process of using fermented Glycine max (L.) extract for enhancing natural killer cell activity and inhibitory activities to GABA and glutamate receptor binding